Instituto de Investigaciones en Ingeniería Genética y Biología Molecular

What Instituto de Investigaciones en Ingeniería Genética y Biología Molecular does

INGEBI (Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres") is an Argentine public, non-profit research institute operated under CONICET, the country's national scientific and technical research council. Founded in 1980 as a CONICET program and elevated to full Institute status in 1983 under the direction of Dr. Héctor N. Torres, INGEBI is headquartered at Vuelta de Obligado 2490, Buenos Aires, within the historic CONICET building. Its mission spans basic and applied research in genetic engineering, molecular biology, parasitology, neuroscience, plant biology, microbial ecology, immunology, and experimental therapeutics, alongside doctoral-level training and technology transfer to the productive sector.

The institute operates 15 research groups covering Chagas disease molecular biology, plant biotechnology and phototransduction, microbial ecology, chromatin structure, hearing genetics and physiology, plant genetic engineering, trypanosomatid signaling, neurodegenerative disease therapeutics, and auditory synaptic transmission. It maintains roughly 27 senior researchers, 28 PhD students, 15 technicians, and 6 administrative staff, and has trained more than 100 doctoral fellows since inception. Its technology platform includes molecular diagnostics (qualitative and quantitative PCR for Trypanosoma cruzi), proteome analysis, gene mutation and polymorphism detection, lentiviral vector production for in vitro and in vivo transduction, hearing loss genetic screening, agrobiotechnology evaluation, and molecular ecology monitoring for methane-oxidizing bacteria.

INGEBI's revenue model is overwhelmingly public-sector: primary funding flows from CONICET, complemented by research grants from Universidad de Buenos Aires (FCEN/UBACYT), SECYT, Fundación Antorchas, the Howard Hughes Medical Institute, PAHO/WHO, UNDP, ICGEB-ONUDI, the European Economic Community, CYTED-D, and French agencies CNRS and INSERM. Private-sector engagement is channeled through the separately constituted Fundación INGEBI, which interfaces with Argentine pharmaceutical and industrial firms (Biosidus, Bagó, Gador, Roemmers, Wiener, Bi ótica-Polychaco, CEDIQUIFA). A growing fee-for-service line — the STANs INGEBI catalog of 12 technological services — provides laboratory analysis, diagnostics, and production services to industry and academia on negotiated terms, supporting technology transfer to the productive sector.

Name

Instituto de Investigaciones en Ingeniería Genética y Biología Molecular

Legal name

Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"

Website

https://ingebi-conicet.gov.ar

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

51–100 employees

Short description

INGEBI is a Buenos Aires-based, CONICET-affiliated non-profit research institute conducting basic and applied research in genetic engineering, molecular biology, parasitology, neuroscience, and plant biology, training doctoral researchers with the University of Buenos Aires and offering fee-for-service laboratory and diagnostic services to industry and academia.

Ownership category

akta.pro rank

Product category

Biotechnology Research Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• Molecular biology research
• Genetic engineering services
• Biotechnology research services
• Parasitology diagnostics
• Plant biotechnology research

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. CONICET Government Funding: Primary funding from CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas), Argentina's national scientific research council
2. Research Grants: Funding from Universidad de Buenos Aires (FCEN, UBACYT program), SECYT (Secretaría de Ciencia y Tecnología), Fundación Antorchas, Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, Howard Hughes Medical Institute, and international agencies
3. International Institutional Funding: Support from WHO, UNDP, European Economic Community, ICGEB-ONUDI, International Foundation for Science (Sweden), CYTED-D (Spain), and French agencies CNRS and INSERM
4. Private Sector Partnerships: Funding through Fundación INGEBI from private companies including Biosidus, Bagó, Gador, Biótica, Roemmers, CEDIQUIFA, Industrias Químicas Almidar, Banco de la Provincia de Buenos Aires
5. Technological Services (STANs): Fee-for-service laboratory analysis and testing services including molecular diagnostics, protein analysis, lentiviral vector production, and biotechnology evaluation services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

INGEBI conducts basic and applied research in genetic engineering and molecular biology, organized into multiple laboratories covering parasitology, plant biology, microbial ecology, and neuroscience. It offers High-Level Technological Services (STANs / Servicios Tecnológicos de Alto Nivel) — fee-for-service laboratory analyses such as DNA sequencing, genotyping, protein production, monoclonal antibody generation, flow cytometry, and pathogen diagnostics — to industry, healthcare, and academic clients. The institute also trains doctoral students and contributes to scientific publications in collaboration with national and international partners.

Product overview

INGEBI is a public research institute (CONICET) offering a portfolio of 12 Technological Services (STANs INGEBI) that provide specialized laboratory analysis and research support services. These services span multiple scientific domains including proteomics, molecular genetics, diagnostics for Chagas disease, agrobiotechnology evaluation, and environmental biotechnology. The services are offered to both industry (for commercial development such as diagnostic kits) and academia (for basic and applied research). The institute does not operate a unified software product but rather provides fee-for-service laboratory capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• High-Level Technological Services (STANs / Servicios Tecnológicos de Alto Nivel) Fee-for-service laboratory analyses and technical services offered by INGEBI to industry, healthcare, and academic clients. Includes DNA sequencing, genotyping, recombinant protein production, monoclonal antibody generation, flow cytometry, cell culture, and diagnostics for Trypanosoma cruzi and Leishmania. Intended for researchers, biotech firms, hospitals, and public health laboratories.
• Doctoral Research Training Program Postgraduate doctoral training program in molecular biology, genetic engineering, and related life sciences disciplines. Intended for graduate students conducting thesis research at INGEBI under CONICET and UBA frameworks.
• Collaborative Research in Parasitology (Chagas and Leishmaniasis) Applied research programs on Trypanosoma cruzi (Chagas disease) and Leishmania (leishmaniasis) covering molecular biology, diagnostics, and pathogenesis. Intended for public health agencies, academic collaborators, and diagnostic laboratories.

Quantifiable outcome

• Over 100 PhDs trained and graduated from the institute
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas)coreStrategic or Co-development Partner · 1 January 1983Primary institutional framework. INGEBI was elevated to institute status under CONICET in 1983 and operates as a national research institute with ongoing operational and financial support.
• Universidad de Buenos Aires (Facultad de Ciencias Exactas y Naturales)coreStrategic or Co-development Partner · 1 January 1983Close association with FCEN-UBA. Several INGEBI researchers serve as professors at the faculty, with one having served as Dean. The institute provides advanced training and research opportunities for UBA students.
• SECYT (Secretaría de Ciencia y Tecnología)coreStrategic or Co-development PartnerNational science and technology secretariat providing research funding and support through various programs.
• INSERM and CNRS (France)coreStrategic or Co-development PartnerFrench national research agencies participating in the Franco-Argentine Cooperation Agreement for advanced training courses, with participation from CONICET and SECYT.
• Pan American Health Organization/World Health Organization (PAHO/WHO)coreStrategic or Co-development PartnerCollaboration on Chagas disease research, diagnostic evaluation, and the Special Program for Research and Training in Tropical Diseases.
• Fundación INGEBIcoreStrategic or Co-development PartnerPrivate foundation established by INGEBI scientists to channel private sector funding and maintain active contacts with companies, banks, and other foundations supporting the institute.
• BiosidusminorStrategic or Co-development PartnerArgentine pharmaceutical company collaborating on research and development activities and supporting Fundación INGEBI.
• Laboratorios GadorminorStrategic or Co-development PartnerArgentine pharmaceutical company with past and ongoing collaborative research agreements with the institute.
• Laboratorios Wiener, Biótica-Polychaco, Bagó, RoemmersminorStrategic or Co-development PartnerArgentine pharmaceutical companies with collaborative research and development agreements through Fundación INGEBI.
• International Centre for Genetic Engineering and Biotechnology (ICGEB-ONUDI)minorStrategic or Co-development PartnerInternational organization providing research support and collaborative opportunities.
• NHEPACHA NetworkminorStrategic or Co-development PartnerInternational network (New Tools for the Diagnosis and Evaluation of Chagas Disease) providing collaboration on standardized clinical databases and diagnostic research.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• IBYME — Instituto de Biología y Medicina Experimental: Sister CONICET research institute also located in Buenos Aires with strong CONICET/UBA ties. Comparable as a public biomedical research institute focused on experimental biology, molecular research, and PhD training under the same national funding framework.
• Centro de Regulación Genómica (CRG): Barcelona-based non-profit biomedical research institute with comparable scope (genomics, molecular biology, bioinformatics) and comparable scale (~400–500 staff, 8–10 research groups). Comparable in operating model as a publicly funded research center offering core services to industry and academia.
• Fundación Instituto Leloir: Argentine CONICET-affiliated research institute conducting molecular biology, genetics and biotechnology research. Most directly comparable peer — same funding ecosystem, same research scope, same government-nonprofit structure, and overlapping focus on plant biology and disease.
• Institut Pasteur de Montevideo: Public biomedical research institute in Uruguay focused on molecular biology, immunology, and infectious disease (including Chagas), with comparable government-affiliated nonprofit structure and similar STANs-style service offerings to industry and academia.

Broad incumbents

• Broad Institute of MIT and Harvard: Joint MIT/Harvard genomics and molecular medicine institute that combines academic research with large-scale genomic services to the scientific community. Relevant peer because it shares INGEBI's blend of basic research, technology services, and PhD-level training in genomics and molecular biology.
• Instituto Butantan: Large Brazilian public research institute focused on immunology, parasitology, and biotechnology (including Chagas-related research). Comparable as a Latin American public-sector biomedical research and biologics-manufacturing organization with overlapping scientific scope.
• Max Planck Institute for Molecular Genetics: Large established European research institute focused on molecular genetics and genomics. Comparable as a publicly funded, non-university research institute running multiple research groups in molecular biology, with parallel graduate training programs.
• European Molecular Biology Laboratory (EMBL): Intergovernmental molecular biology research organization with comparable mandate in basic research, training, and technology services. A larger, better-funded incumbent whose operating model (molecular biology research + services + international training) closely parallels INGEBI's structure.
• Whitehead Institute for Biomedical Research: MIT-affiliated non-profit biomedical research institute with a comparable model: independent research groups, PhD training, and industry collaborations. Operates at a much larger scale but shares the mission of basic molecular biology research with applied and translational spillovers.

Regional players

• Centre for Genomic Regulation (CRG) — see above: Comparable European peer in genomics/molecular biology research operating outside INGEBI's geography; relevant as a benchmark for how a publicly funded mid-sized research institute can commercialize STANs internationally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ingebi-conicet

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Investigaciones en Ingeniería Genética y Biología Molecular